Abstract
BackgroundThe development of high-throughput technologies for the global measurement of MicroRNAs (miRNAs), allowed these regulatory molecules to emerge as a new class of biomarkers in several diseases, including systemic lupus...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
